Posted inBiotechnology
Alumis crushed by midstage lupus flop but plots path to phase 3 for TYK2 inhibitor
A phase 2b lupus trial of Alumis’ envudeucitinib has missed its primary and secondary endpoints. But the biotech is still…
Posted inMedical Technology
Novocure hit by cyberattack exposing patient data
Novocure has become the latest medtech company to be hit by a cyberattack, with the oncology specialist revealing that unauthorized…
Posted inBiotechnology
GSK catches phase 3 fever after mRNA flu vaccine beats standard shots
GSK has linked its mRNA seasonal flu vaccine candidate to higher immune responses than conventional jabs in a phase 2…
Posted inMedical Technology
Boston Scientific halts sales of angiographic catheters amid ‘two serious injuries’
Boston Scientific has told its customers to stop using its Imager II angiographic catheters upon learning that a manufacturing issue…